Satouchi K et al. |
Application of selected ion monitoring to determination of platelet-activating factor. |
1983 |
J. Biochem. |
pmid:6423622
|
Hillmar I and Zöllner N |
Saturated and unsaturated 1-0-alkyl-2-0-acetoyl-sn-glycero-3-phosphocholines and 2-lyso derivatives from ratfish liver oil. Effect on adenosine 3':5'-cyclic monophosphate concentration in hepatocyte suspensions. |
1983 |
Res Exp Med (Berl) |
pmid:6310713
|
Mauco G et al. |
Platelet activating factor (PAF-acether) promotes an early degradation of phosphatidylinositol-4,5-biphosphate in rabbit platelets. |
1983 |
FEBS Lett. |
pmid:6311620
|
Camussi G et al. |
Release of platelet activating factor in rabbits with antibody-mediated injury of the lung: the role of leukocytes and of pulmonary endothelial cells. |
1983 |
J. Immunol. |
pmid:6311899
|
Hwang SB et al. |
Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes. |
1983 |
Biochemistry |
pmid:6313047
|
Shukla SD and Hanahan DJ |
An early transient decrease in phosphatidylinositol 4,5-bisphosphate upon stimulation of rabbit platelets with acetylglycerylether phosphorylcholine (platelet activating factor). |
1983 |
Arch. Biochem. Biophys. |
pmid:6320731
|
McManus LM et al. |
Thromboxane B2 (TxB2) release following acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbit. |
1983 |
Immunopharmacology |
pmid:6832960
|
Otsuka A et al. |
alpha-Adrenergic blocking action of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in rats. |
1983 |
Clin Exp Hypertens A |
pmid:6133661
|
Jouvin-Marche E et al. |
Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils. |
1983 |
Eur. J. Pharmacol. |
pmid:6134631
|
Sano K et al. |
A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions. |
1983 |
J. Biol. Chem. |
pmid:6218169
|
Vargaftig BB et al. |
Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent. |
1983 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:6221558
|
Voelkel NF et al. |
Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation. |
1983 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:6221590
|
Kloprogge E et al. |
Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets. |
1983 |
Thromb. Res. |
pmid:6222507
|
Bessin P et al. |
Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. |
1983 |
Eur. J. Pharmacol. |
pmid:6687572
|
Mueller HW et al. |
1-O-alkyl-linked phosphoglycerides of human platelets: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species. |
1983 |
Lipids |
pmid:6419001
|
Shukla SD et al. |
Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis. |
1983 |
J. Biol. Chem. |
pmid:6309795
|
Hallam TJ et al. |
The role of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AcGEPC) and palmitoyl-lysophosphatidate in the responses of human blood platelets to collagen and thrombin. |
1983 |
FEBS Lett. |
pmid:6617886
|
Roussi J et al. |
[Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia]. |
1983 |
Nouv Rev Fr Hematol |
pmid:6622253
|
Valone FH and Goetzl EJ |
Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC). |
1983 |
Am. J. Pathol. |
pmid:6624880
|
Barradas MA et al. |
The effect of fenfluramine on collagen-induced platelet aggregation in vitro. |
1983 |
Br J Clin Pharmacol |
pmid:6626443
|
Korth R et al. |
1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines: influence on aggregation and [3H]serotonin release of human thrombocytes. |
1983 |
Chem. Phys. Lipids |
pmid:6627525
|
Moschidis MC et al. |
Phosphono-platelet activating factor I. Synthesis of 1-O-hexadecyl-2-O-acetyl-glyceryl-3-(2-trimethyl ammonium-methyl) phosphonate and its platelet activating potency. |
1983 |
Chem. Phys. Lipids |
pmid:6627527
|
Heffner JE et al. |
Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2. |
1983 |
J. Clin. Invest. |
pmid:6822668
|
Randolph AE et al. |
Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats. |
1983 |
Clin Exp Hypertens A |
pmid:6684006
|
Morley J et al. |
Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. |
1983 |
Br. J. Pharmacol. |
pmid:6685552
|
Hornby EJ and Perry CR |
1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen. |
1983 |
Thromb. Haemost. |
pmid:6636035
|
Patterson R and Harris KE |
The activity of aerosolized and intracutaneous synthetic platelet activating factor (AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys. |
1983 |
J. Lab. Clin. Med. |
pmid:6644157
|
Nunn B |
Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation. |
1983 |
Thromb. Res. |
pmid:6648898
|
Myers A et al. |
Glucocorticoid protection against PAF-acether toxicity in mice. |
1983 |
Br. J. Pharmacol. |
pmid:6652344
|
Cervoni P et al. |
Aortic vascular and atrial responses to (+/-)-1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine. |
1983 |
Br. J. Pharmacol. |
pmid:6652348
|
Benveniste J et al. |
The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations. |
1983 |
Br. J. Pharmacol. |
pmid:6652376
|
Garcia Gil M and Sanchez Crespo M |
Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes. |
1983 |
Immunopharmacology |
pmid:6654649
|
Tokumura A et al. |
Biphasic action of platelet-activating factor on isolated guinea-pig ileum. |
1983 |
Lipids |
pmid:6656539
|
Hamasaki Y et al. |
[Effects of platelet activating factor (PAF:AGEPC) on airway and pulmonary vascular constriction of guinea pigs--with special reference to the relation with TXA2]. |
1983 |
Kokyu To Junkan |
pmid:6658209
|
Björk J et al. |
Paf-acether (platelet-activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds. |
1983 |
Acta Physiol. Scand. |
pmid:6659994
|
Björk J and Smedegård G |
Acute microvascular effects of PAF-acether, as studied by intravital microscopy. |
1983 |
Eur. J. Pharmacol. |
pmid:6662199
|
Holt PG et al. |
Platelet serotonin release by human polymorphonuclear leucocytes stimulated by cotton dust bacteria. |
1983 |
Clin. Exp. Immunol. |
pmid:6831770
|
McDonald TP and Kalmaz GD |
Effects of thrombopoietin on the number and diameter of marrow megakaryocytes of mice. |
1983 |
Exp. Hematol. |
pmid:6832243
|
Lewis JC et al. |
Platelet-activating factor effects on pulmonary ultrastructure in rabbits. |
1983 |
Exp. Mol. Pathol. |
pmid:6832335
|
Levy JV |
Calmodulin antagonists inhibit aggregation of human, guniea pig and rabbit platelets induced with platelet activating factor. |
1983 |
FEBS Lett. |
pmid:6832368
|
Touqui L et al. |
Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6838557
|
Worthen GS et al. |
Platelet-activating factor causes neutrophil accumulation and edema in rabbit lungs. |
1983 |
Chest |
pmid:6839840
|
Heffner JE et al. |
Platelet-induced pulmonary hypertension and edema. A mechanism involving acetyl glyceryl ether phosphorylcholine and thromboxane A2. |
1983 |
Chest |
pmid:6839854
|
Virella G et al. |
Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes. |
1983 |
Immunology |
pmid:6885111
|
Camussi G et al. |
Platelet-activating factor-mediated contraction of rabbit lung strips: pharmacologic modulation. |
1983 |
Immunopharmacology |
pmid:6885382
|
O'Flaherty JT and Wykle RL |
Biology and biochemistry of platelet-activating factor. |
1983 |
Clin Rev Allergy |
pmid:6370406
|
Tiffany ML |
Technical considerations for platelet aggregation and related problems. |
1983 |
Crit Rev Clin Lab Sci |
pmid:6370596
|
Vermylen J et al. |
Normal mechanisms of platelet function. |
1983 |
Clin Haematol |
pmid:6301715
|
Camussi G et al. |
The release of platelet-activating factor from human endothelial cells in culture. |
1983 |
J. Immunol. |
pmid:6415166
|
Bonnet J et al. |
Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig. |
1983 |
Prostaglandins |
pmid:6419289
|